Global and Japan Imipenem API Market Insights, Forecast to 2027

SKU ID :QYR-19208991 | Published Date: 23-Sep-2021 | No. of pages: 158
1 Study Coverage 1.1 Imipenem API Product Introduction 1.2 Market by Type 1.2.1 Global Imipenem API Market Size Growth Rate by Type 1.2.2 Aseptic API 1.2.3 Non-sterile API 1.3 Market by Application 1.3.1 Global Imipenem API Market Size Growth Rate by Application 1.3.2 Intramuscular Injection 1.3.3 Static Drops 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Imipenem API Market Size, Estimates and Forecasts 2.1.1 Global Imipenem API Revenue 2016-2027 2.1.2 Global Imipenem API Sales 2016-2027 2.2 Global Imipenem API, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Imipenem API Historical Market Size by Region (2016-2021) 2.3.1 Global Imipenem API Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Imipenem API Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Imipenem API Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Imipenem API Sales Forecast by Region (2022-2027) 2.4.2 Global Imipenem API Revenue Forecast by Region (2022-2027) 3 Global Imipenem API Competitor Landscape by Players 3.1 Global Top Imipenem API Manufacturers by Sales 3.1.1 Global Imipenem API Sales by Manufacturer (2016-2021) 3.1.2 Global Imipenem API Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Imipenem API Manufacturers by Revenue 3.2.1 Key Imipenem API Manufacturers Covered: Ranking by Revenue 3.2.2 Global Imipenem API Revenue by Manufacturers (2016-2021) 3.2.3 Global Imipenem API Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Imipenem API Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Imipenem API Revenue in 2020 3.2.6 Global Imipenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Imipenem API Price by Manufacturers 3.4 Global Imipenem API Manufacturing Base Distribution, Product Types 3.4.1 Imipenem API Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Imipenem API Product Type 3.4.3 Date of International Manufacturers Enter into Imipenem API Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Imipenem API Market Size by Type (2016-2021) 4.1.1 Global Imipenem API Sales by Type (2016-2021) 4.1.2 Global Imipenem API Revenue by Type (2016-2021) 4.1.3 Imipenem API Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Imipenem API Market Size Forecast by Type (2022-2027) 4.2.1 Global Imipenem API Sales Forecast by Type (2022-2027) 4.2.2 Global Imipenem API Revenue Forecast by Type (2022-2027) 4.2.3 Imipenem API Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Imipenem API Market Size by Application (2016-2021) 5.1.1 Global Imipenem API Sales by Application (2016-2021) 5.1.2 Global Imipenem API Revenue by Application (2016-2021) 5.1.3 Imipenem API Price by Application (2016-2021) 5.2 Imipenem API Market Size Forecast by Application (2022-2027) 5.2.1 Global Imipenem API Sales Forecast by Application (2022-2027) 5.2.2 Global Imipenem API Revenue Forecast by Application (2022-2027) 5.2.3 Global Imipenem API Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Imipenem API Market Size YoY Growth 2016-2027 6.1.1 Japan Imipenem API Sales YoY Growth 2016-2027 6.1.2 Japan Imipenem API Revenue YoY Growth 2016-2027 6.1.3 Japan Imipenem API Market Share in Global Market 2016-2027 6.2 Japan Imipenem API Market Size by Players (International and Local Players) 6.2.1 Japan Top Imipenem API Players by Sales (2016-2021) 6.2.2 Japan Top Imipenem API Players by Revenue (2016-2021) 6.3 Japan Imipenem API Historic Market Review by Type (2016-2021) 6.3.1 Japan Imipenem API Sales Market Share by Type (2016-2021) 6.3.2 Japan Imipenem API Revenue Market Share by Type (2016-2021) 6.3.3 Japan Imipenem API Price by Type (2016-2021) 6.4 Japan Imipenem API Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Imipenem API Sales Forecast by Type (2022-2027) 6.4.2 Japan Imipenem API Revenue Forecast by Type (2022-2027) 6.4.3 Japan Imipenem API Price Forecast by Type (2022-2027) 6.5 Japan Imipenem API Historic Market Review by Application (2016-2021) 6.5.1 Japan Imipenem API Sales Market Share by Application (2016-2021) 6.5.2 Japan Imipenem API Revenue Market Share by Application (2016-2021) 6.5.3 Japan Imipenem API Price by Application (2016-2021) 6.6 Japan Imipenem API Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Imipenem API Sales Forecast by Application (2022-2027) 6.6.2 Japan Imipenem API Revenue Forecast by Application (2022-2027) 6.6.3 Japan Imipenem API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Imipenem API Market Size YoY Growth 2016-2027 7.2 North America Imipenem API Market Facts & Figures by Country 7.2.1 North America Imipenem API Sales by Country (2016-2021) 7.2.2 North America Imipenem API Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Imipenem API Market Size YoY Growth 2016-2027 8.2 Asia Pacific Imipenem API Market Facts & Figures by Region 8.2.1 Asia Pacific Imipenem API Sales by Region (2016-2021) 8.2.2 Asia Pacific Imipenem API Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Imipenem API Market Size YoY Growth 2016-2027 9.2 Europe Imipenem API Market Facts & Figures by Country 9.2.1 Europe Imipenem API Sales by Country (2016-2021) 9.2.2 Europe Imipenem API Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Imipenem API Market Size YoY Growth 2016-2027 10.2 Latin America Imipenem API Market Facts & Figures by Country 10.2.1 Latin America Imipenem API Sales by Country (2016-2021) 10.2.2 Latin America Imipenem API Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Imipenem API Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Imipenem API Market Facts & Figures by Country 11.2.1 Middle East and Africa Imipenem API Sales by Country (2016-2021) 11.2.2 Middle East and Africa Imipenem API Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Hospira 12.1.1 Hospira Corporation Information 12.1.2 Hospira Description and Business Overview 12.1.3 Hospira Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Hospira Imipenem API Products Offered 12.1.5 Hospira Recent Development 12.2 ACS DOBFAR SPA 12.2.1 ACS DOBFAR SPA Corporation Information 12.2.2 ACS DOBFAR SPA Description and Business Overview 12.2.3 ACS DOBFAR SPA Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.2.4 ACS DOBFAR SPA Imipenem API Products Offered 12.2.5 ACS DOBFAR SPA Recent Development 12.3 High Science 12.3.1 High Science Corporation Information 12.3.2 High Science Description and Business Overview 12.3.3 High Science Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.3.4 High Science Imipenem API Products Offered 12.3.5 High Science Recent Development 12.4 Jeil Pharmaceutica 12.4.1 Jeil Pharmaceutica Corporation Information 12.4.2 Jeil Pharmaceutica Description and Business Overview 12.4.3 Jeil Pharmaceutica Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Jeil Pharmaceutica Imipenem API Products Offered 12.4.5 Jeil Pharmaceutica Recent Development 12.5 Choongwae Pharma Corporation 12.5.1 Choongwae Pharma Corporation Corporation Information 12.5.2 Choongwae Pharma Corporation Description and Business Overview 12.5.3 Choongwae Pharma Corporation Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Choongwae Pharma Corporation Imipenem API Products Offered 12.5.5 Choongwae Pharma Corporation Recent Development 12.6 Sun Pharmaceutical 12.6.1 Sun Pharmaceutical Corporation Information 12.6.2 Sun Pharmaceutical Description and Business Overview 12.6.3 Sun Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Sun Pharmaceutical Imipenem API Products Offered 12.6.5 Sun Pharmaceutical Recent Development 12.7 Sandoz 12.7.1 Sandoz Corporation Information 12.7.2 Sandoz Description and Business Overview 12.7.3 Sandoz Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Sandoz Imipenem API Products Offered 12.7.5 Sandoz Recent Development 12.8 Kaliberr 12.8.1 Kaliberr Corporation Information 12.8.2 Kaliberr Description and Business Overview 12.8.3 Kaliberr Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Kaliberr Imipenem API Products Offered 12.8.5 Kaliberr Recent Development 12.9 Auronext Pharma 12.9.1 Auronext Pharma Corporation Information 12.9.2 Auronext Pharma Description and Business Overview 12.9.3 Auronext Pharma Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Auronext Pharma Imipenem API Products Offered 12.9.5 Auronext Pharma Recent Development 12.10 Nectar Lifesciences 12.10.1 Nectar Lifesciences Corporation Information 12.10.2 Nectar Lifesciences Description and Business Overview 12.10.3 Nectar Lifesciences Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Nectar Lifesciences Imipenem API Products Offered 12.10.5 Nectar Lifesciences Recent Development 12.11 Hospira 12.11.1 Hospira Corporation Information 12.11.2 Hospira Description and Business Overview 12.11.3 Hospira Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Hospira Imipenem API Products Offered 12.11.5 Hospira Recent Development 12.12 Zhuhai United Laboratorie 12.12.1 Zhuhai United Laboratorie Corporation Information 12.12.2 Zhuhai United Laboratorie Description and Business Overview 12.12.3 Zhuhai United Laboratorie Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Zhuhai United Laboratorie Products Offered 12.12.5 Zhuhai United Laboratorie Recent Development 12.13 SUZHOU HOMESUN PHARMACEUTICAL 12.13.1 SUZHOU HOMESUN PHARMACEUTICAL Corporation Information 12.13.2 SUZHOU HOMESUN PHARMACEUTICAL Description and Business Overview 12.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.13.4 SUZHOU HOMESUN PHARMACEUTICAL Products Offered 12.13.5 SUZHOU HOMESUN PHARMACEUTICAL Recent Development 12.14 Unimark Remedies 12.14.1 Unimark Remedies Corporation Information 12.14.2 Unimark Remedies Description and Business Overview 12.14.3 Unimark Remedies Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Unimark Remedies Products Offered 12.14.5 Unimark Remedies Recent Development 12.15 Zhejiang Haixiang Pharmaceutical 12.15.1 Zhejiang Haixiang Pharmaceutical Corporation Information 12.15.2 Zhejiang Haixiang Pharmaceutical Description and Business Overview 12.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Zhejiang Haixiang Pharmaceutical Products Offered 12.15.5 Zhejiang Haixiang Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Imipenem API Industry Trends 13.2 Imipenem API Market Drivers 13.3 Imipenem API Market Challenges 13.4 Imipenem API Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Imipenem API Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
List of Tables Table 1. Global Imipenem API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Aseptic API Table 3. Major Manufacturers of Non-sterile API Table 4. Global Imipenem API Market Size Growth Rate by Application (2021-2027) & (KG) Table 5. Global Imipenem API Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Imipenem API Sales by Regions (2016-2021) & (KG) Table 7. Global Imipenem API Sales Market Share by Regions (2016-2021) Table 8. Global Imipenem API Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Imipenem API Sales Forecast by Region (2022-2027) & (KG) Table 10. Global Imipenem API Sales Market Share Forecast by Region (2022-2027) Table 11. Global Imipenem API Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Imipenem API Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Imipenem API Sales by Manufacturers (2016-2021) (KG) Table 14. Global Imipenem API Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Imipenem API Manufacturers by Revenue (US$ Million) in 2020 Table 16. Imipenem API Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Imipenem API Revenue Share by Manufacturers (2016-2021) Table 18. Global Imipenem API Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Imipenem API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imipenem API as of 2020) Table 20. Key Manufacturers Imipenem API Price (2016-2021) (US$/G) Table 21. Imipenem API Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Imipenem API Product Type Table 23. Date of International Manufacturers Enter into Imipenem API Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Imipenem API Sales by Type (2016-2021) (KG) Table 26. Global Imipenem API Sales Share by Type (2016-2021) Table 27. Global Imipenem API Revenue by Type (2016-2021) (US$ Million) Table 28. Global Imipenem API Revenue Share by Type (2016-2021) Table 29. Imipenem API Average Selling Price (ASP) by Type (2016-2021) & (US$/G) Table 30. Global Imipenem API Sales Forecast by Type (2022-2027) & (KG) Table 31. Global Imipenem API Sales Market Share Forecast by Type (2022-2027) Table 32. Global Imipenem API Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Imipenem API Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Imipenem API Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G) Table 35. Global Imipenem API Sales by Application (2016-2021) (KG) Table 36. Global Imipenem API Sales Share by Application (2016-2021) Table 37. Global Imipenem API Revenue by Application (2016-2021) (US$ Million) Table 38. Global Imipenem API Revenue Share by Application (2016-2021) Table 39. Imipenem API Average Selling Price (ASP) by Application (2016-2021) & (US$/G) Table 40. Global Imipenem API Sales Forecast by Application (2022-2027) & (KG) Table 41. Global Imipenem API Sales Market Share Forecast by Application (2022-2027) Table 42. Global Imipenem API Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Imipenem API Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Imipenem API Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G) Table 45. Japan Imipenem API Sales (KG) of Key Companies (2016-2021) Table 46. Japan Imipenem API Sales Share by Company (2016-2021) Table 47. Japan Imipenem API Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Imipenem API Revenue Share by Company (2016-2021) Table 49. Japan Imipenem API Sales (KG) by Type (2016-2021) Table 50. Japan Imipenem API Sales Share by Type (2016-2021) Table 51. Japan Imipenem API Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Imipenem API Price (US$/G) by Type (2016-2021) Table 53. Japan Imipenem API Sales (KG) by Type (2022-2027) Table 54. Japan Imipenem API Sales Share by Type (2022-2027) Table 55. Japan Imipenem API Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Imipenem API Revenue Share by Type (2022-2027) Table 57. Japan Imipenem API Price (US$/G) by Type (2022-2027) Table 58. Japan Imipenem API Sales (KG) by Application (2016-2021) Table 59. Japan Imipenem API Sales Share by Application (2016-2021) Table 60. Japan Imipenem API Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Imipenem API Price (US$/G) by Application (2016-2021) Table 62. Japan Imipenem API Sales (KG) by Application (2022-2027) Table 63. Japan Imipenem API Sales Share by Application (2022-2027) Table 64. Japan Imipenem API Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Imipenem API Revenue Share by Application (2022-2027) Table 66. Japan Imipenem API Price (US$/G) by Application (2022-2027) Table 67. North America Imipenem API Sales by Country (2016-2021) & (KG) Table 68. North America Imipenem API Sales Market Share by Country (2016-2021) Table 69. North America Imipenem API Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Imipenem API Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Imipenem API Sales by Region (2016-2021) & (KG) Table 72. Asia Pacific Imipenem API Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Imipenem API Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Imipenem API Revenue Market Share by Region (2016-2021) Table 75. Europe Imipenem API Sales by Country (2016-2021) & (KG) Table 76. Europe Imipenem API Sales Market Share by Country (2016-2021) Table 77. Europe Imipenem API Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Imipenem API Revenue Market Share by Country (2016-2021) Table 79. Latin America Imipenem API Sales by Country (2016-2021) & (KG) Table 80. Latin America Imipenem API Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Imipenem API Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Imipenem API Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Imipenem API Sales by Country (2016-2021) & (KG) Table 84. Middle East and Africa Imipenem API Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Imipenem API Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Imipenem API Revenue Market Share by Country (2016-2021) Table 87. Hospira Corporation Information Table 88. Hospira Description and Business Overview Table 89. Hospira Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 90. Hospira Imipenem API Product Table 91. Hospira Recent Development Table 92. ACS DOBFAR SPA Corporation Information Table 93. ACS DOBFAR SPA Description and Business Overview Table 94. ACS DOBFAR SPA Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 95. ACS DOBFAR SPA Product Table 96. ACS DOBFAR SPA Recent Development Table 97. High Science Corporation Information Table 98. High Science Description and Business Overview Table 99. High Science Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 100. High Science Product Table 101. High Science Recent Development Table 102. Jeil Pharmaceutica Corporation Information Table 103. Jeil Pharmaceutica Description and Business Overview Table 104. Jeil Pharmaceutica Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 105. Jeil Pharmaceutica Product Table 106. Jeil Pharmaceutica Recent Development Table 107. Choongwae Pharma Corporation Corporation Information Table 108. Choongwae Pharma Corporation Description and Business Overview Table 109. Choongwae Pharma Corporation Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 110. Choongwae Pharma Corporation Product Table 111. Choongwae Pharma Corporation Recent Development Table 112. Sun Pharmaceutical Corporation Information Table 113. Sun Pharmaceutical Description and Business Overview Table 114. Sun Pharmaceutical Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 115. Sun Pharmaceutical Product Table 116. Sun Pharmaceutical Recent Development Table 117. Sandoz Corporation Information Table 118. Sandoz Description and Business Overview Table 119. Sandoz Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 120. Sandoz Product Table 121. Sandoz Recent Development Table 122. Kaliberr Corporation Information Table 123. Kaliberr Description and Business Overview Table 124. Kaliberr Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 125. Kaliberr Product Table 126. Kaliberr Recent Development Table 127. Auronext Pharma Corporation Information Table 128. Auronext Pharma Description and Business Overview Table 129. Auronext Pharma Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 130. Auronext Pharma Product Table 131. Auronext Pharma Recent Development Table 132. Nectar Lifesciences Corporation Information Table 133. Nectar Lifesciences Description and Business Overview Table 134. Nectar Lifesciences Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 135. Nectar Lifesciences Product Table 136. Nectar Lifesciences Recent Development Table 137. Savior Lifetec Corporation Corporation Information Table 138. Savior Lifetec Corporation Description and Business Overview Table 139. Savior Lifetec Corporation Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 140. Savior Lifetec Corporation Product Table 141. Savior Lifetec Corporation Recent Development Table 142. Zhuhai United Laboratorie Corporation Information Table 143. Zhuhai United Laboratorie Description and Business Overview Table 144. Zhuhai United Laboratorie Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 145. Zhuhai United Laboratorie Product Table 146. Zhuhai United Laboratorie Recent Development Table 147. SUZHOU HOMESUN PHARMACEUTICAL Corporation Information Table 148. SUZHOU HOMESUN PHARMACEUTICAL Description and Business Overview Table 149. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 150. SUZHOU HOMESUN PHARMACEUTICAL Product Table 151. SUZHOU HOMESUN PHARMACEUTICAL Recent Development Table 152. Unimark Remedies Corporation Information Table 153. Unimark Remedies Description and Business Overview Table 154. Unimark Remedies Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 155. Unimark Remedies Product Table 156. Unimark Remedies Recent Development Table 157. Zhejiang Haixiang Pharmaceutical Corporation Information Table 158. Zhejiang Haixiang Pharmaceutical Description and Business Overview Table 159. Zhejiang Haixiang Pharmaceutical Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021) Table 160. Zhejiang Haixiang Pharmaceutical Product Table 161. Zhejiang Haixiang Pharmaceutical Recent Development Table 162. Imipenem API Market Trends Table 163. Imipenem API Market Drivers Table 164. Imipenem API Market Challenges Table 165. Imipenem API Market Restraints Table 166. Imipenem API Customers List Table 167. Imipenem API Distributors List Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Imipenem API Product Picture Figure 2. Global Imipenem API Sales Market Share by Type in 2020 & 2027 Figure 3. Aseptic API Product Picture Figure 4. Non-sterile API Product Picture Figure 5. Global Imipenem API Sales Market Share by Application in 2020 & 2027 Figure 6. Intramuscular Injection Figure 7. Static Drops Figure 8. Imipenem API Report Years Considered Figure 9. Global Imipenem API Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Imipenem API Market Size 2016-2027 (US$ Million) Figure 11. Global Imipenem API Sales 2016-2027 (KG) Figure 12. Global Imipenem API Market Size Market Share by Region: 2021 Versus 2027 Figure 13. Global Imipenem API Sales Market Share by Region (2016-2021) Figure 14. Global Imipenem API Sales Market Share by Region in 2020 Figure 15. Global Imipenem API Revenue Market Share by Region (2016-2021) Figure 16. Global Imipenem API Revenue Market Share by Region in 2020 Figure 17. Global Imipenem API Sales Share by Manufacturer in 2020 Figure 18. The Top 10 and 5 Players Market Share by Imipenem API Revenue in 2020 Figure 19. Imipenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Imipenem API Sales Market Share by Type (2016-2021) Figure 21. Global Imipenem API Sales Market Share by Type in 2020 Figure 22. Global Imipenem API Revenue Market Share by Type (2016-2021) Figure 23. Global Imipenem API Revenue Market Share by Type in 2020 Figure 24. Global Imipenem API Sales Market Share by Application (2016-2021) Figure 25. Global Imipenem API Sales Market Share by Application in 2020 Figure 26. Global Imipenem API Revenue Market Share by Application (2016-2021) Figure 27. Global Imipenem API Revenue Market Share by Application in 2020 Figure 28. Japan Imipenem API Sales Growth Rate 2016-2027 (KG) Figure 29. Japan Imipenem API Revenue Growth Rate 2016-2027 (US$ Million) Figure 30. Japan Imipenem API Market Share in Global Market 2016-2027 Figure 31. Japan 5 and 10 Largest Imipenem API Players Market Share by Revenue in Imipenem API in 2020 Figure 32. Japan Imipenem API Revenue Share by Type (2016-2021) Figure 33. Japan Imipenem API Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Japan Imipenem API Revenue Share by Application (2016-2021) Figure 35. Japan Imipenem API Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Imipenem API Sales Growth Rate 2016-2021 (KG) Figure 37. North America Imipenem API Revenue Growth Rate 2016-2021 (US$ Million) Figure 38. North America Imipenem API Sales Market Share by Country in 2020 Figure 39. North America Imipenem API Revenue Market Share by Country in 2020 Figure 40. U.S. Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 41. U.S. Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Canada Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 43. Canada Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Europe Imipenem API Sales Growth Rate 2016-2021 (KG) Figure 45. Europe Imipenem API Revenue Growth Rate 2016-2021 (US$ Million) Figure 46. Europe Imipenem API Sales Market Share by Country in 2020 Figure 47. Europe Imipenem API Revenue Market Share by Country in 2020 Figure 48. Germany Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 49. Germany Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. France Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 51. France Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. U.K. Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 53. U.K. Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. Italy Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 55. Italy Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Russia Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 57. Russia Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Asia Pacific Imipenem API Sales Growth Rate 2016-2021 (KG) Figure 59. Asia Pacific Imipenem API Revenue Growth Rate 2016-2021 (US$ Million) Figure 60. Asia Pacific Imipenem API Sales Market Share by Region in 2020 Figure 61. Asia Pacific Imipenem API Revenue Market Share by Region in 2020 Figure 62. China Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 63. China Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 64. Japan Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 65. Japan Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. South Korea Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 67. South Korea Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. India Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 69. India Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. Australia Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 71. Australia Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Taiwan Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 73. Taiwan Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Indonesia Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 75. Indonesia Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Thailand Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 77. Thailand Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Malaysia Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 79. Malaysia Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Philippines Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 81. Philippines Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Vietnam Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 83. Vietnam Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Latin America Imipenem API Sales Growth Rate 2016-2021 (KG) Figure 85. Latin America Imipenem API Revenue Growth Rate 2016-2021 (US$ Million) Figure 86. Latin America Imipenem API Sales Market Share by Country in 2020 Figure 87. Latin America Imipenem API Revenue Market Share by Country in 2020 Figure 88. Mexico Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 89. Mexico Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Brazil Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 91. Brazil Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Argentina Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 93. Argentina Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Middle East and Africa Imipenem API Sales Growth Rate 2016-2021 (KG) Figure 95. Middle East and Africa Imipenem API Revenue Growth Rate 2016-2021 (US$ Million) Figure 96. Middle East and Africa Imipenem API Sales Market Share by Country in 2020 Figure 97. Middle East and Africa Imipenem API Revenue Market Share by Country in 2020 Figure 98. Turkey Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 99. Turkey Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Saudi Arabia Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 101. Saudi Arabia Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. UAE Imipenem API Sales Growth Rate (2016-2021) (KG) Figure 103. UAE Imipenem API Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Imipenem API Value Chain Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed
Hospira ACS DOBFAR SPA High Science Jeil Pharmaceutica Choongwae Pharma Corporation Sun Pharmaceutical Sandoz Kaliberr Auronext Pharma Nectar Lifesciences Savior Lifetec Corporation Zhuhai United Laboratorie SUZHOU HOMESUN PHARMACEUTICAL Unimark Remedies Zhejiang Haixiang Pharmaceutical
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients